• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ticagrelor and Endothelial Function: An Effect That Persists Far From the Acute Phase and in Monotherapy.

作者信息

Pavasini Rita, Campo Gianluca

机构信息

UO Cardiologia, Azienda Ospedaliero Universitaria di Ferrara, Italy.

出版信息

Arterioscler Thromb Vasc Biol. 2022 Jun;42(6):799-801. doi: 10.1161/ATVBAHA.122.317693. Epub 2022 Apr 21.

DOI:10.1161/ATVBAHA.122.317693
PMID:35443794
Abstract
摘要

相似文献

1
Ticagrelor and Endothelial Function: An Effect That Persists Far From the Acute Phase and in Monotherapy.
Arterioscler Thromb Vasc Biol. 2022 Jun;42(6):799-801. doi: 10.1161/ATVBAHA.122.317693. Epub 2022 Apr 21.
2
Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events.使用总缺血和出血事件对随机化全球领导者试验进行比较方法学评估。
Circ Cardiovasc Qual Outcomes. 2020 Aug;13(8):e006660. doi: 10.1161/CIRCOUTCOMES.120.006660. Epub 2020 Jul 30.
3
Ticagrelor monotherapy following percutaneous coronary intervention for acute coronary syndrome in TWILIGHT patients: still a future for aspirin?
Eur Heart J. 2021 Jul 15;42(27):2708-2709. doi: 10.1093/eurheartj/ehab037.
4
Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial.经皮冠状动脉介入治疗后替格瑞洛单药治疗与替格瑞洛联合阿司匹林治疗患者的药效学比较： TEMPLATE（替格瑞洛单药治疗和血小板反应性）随机对照试验。
J Am Heart Assoc. 2020 Dec 15;9(24):e016495. doi: 10.1161/JAHA.120.016495. Epub 2020 Dec 11.
5
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.替格瑞洛单药治疗与替格瑞洛联合阿司匹林用于非ST段抬高型急性冠状动脉综合征患者经皮冠状动脉介入治疗后：TWILIGHT-ACS研究
Eur Heart J. 2020 Oct 1;41(37):3533-3545. doi: 10.1093/eurheartj/ehaa670.
6
Ticagrelor monotherapy in patients undergoing percutaneous coronary intervention for bifurcation lesions.替格瑞洛单药治疗行经皮冠状动脉介入治疗的分叉病变患者。
Catheter Cardiovasc Interv. 2020 Jul;96(1):112-113. doi: 10.1002/ccd.29082.
7
Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Acute Coronary Syndrome Patients With a High Risk of Ischemic Events.替格瑞洛单药治疗与替格瑞洛联合阿司匹林治疗缺血事件高危急性冠状动脉综合征患者。
Circ Cardiovasc Interv. 2021 Aug;14(8):e010812. doi: 10.1161/CIRCINTERVENTIONS.121.010812. Epub 2021 Jul 20.
8
Ticagrelor with or without Aspirin in High-Risk Patients after PCI.替格瑞洛联合或不联合阿司匹林用于 PCI 术后高危患者。
N Engl J Med. 2019 Nov 21;381(21):2032-2042. doi: 10.1056/NEJMoa1908419. Epub 2019 Sep 26.
9
Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS).经皮冠状动脉介入治疗中（来自 GLOBAL LEADERS 的亚研究） 1 个月双联抗血小板治疗（替格瑞洛+阿司匹林）后序贯 23 个月替格瑞洛单药治疗的安全性和有效性。
Am J Cardiol. 2021 Jan 1;138:1-10. doi: 10.1016/j.amjcard.2020.09.057. Epub 2020 Oct 13.
10
Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.接受复杂经皮冠状动脉介入治疗的患者在 1 个月双联抗血小板治疗后长期使用替格瑞洛单药治疗的影响：来自全球领导者试验的见解。
Eur Heart J. 2019 Aug 14;40(31):2595-2604. doi: 10.1093/eurheartj/ehz453.

引用本文的文献

1
Impact of renal function on Ticagrelor-induced antiplatelet effects in coronary artery disease patients.肾功能对冠心病患者替格瑞洛诱导的抗血小板作用的影响。
Int J Cardiol Heart Vasc. 2023 Mar 27;46:101195. doi: 10.1016/j.ijcha.2023.101195. eCollection 2023 Jun.